Concentrations |
12 Months Ended |
|---|---|
Dec. 31, 2023 | |
| Risks and Uncertainties [Abstract] | |
| Concentrations |
Note L – Concentrations Revenue from the Company’s Remote Power Patent constituted 100% of the Company’s revenue for the year ended December 31, 2023, of which four parties constitute an aggregate of 90% of the Company’s revenue for such year. The Company had no revenue for the year ended December 31, 2022. |
| X | ||||||||||
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|